- We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangogenic treatment.
- Publication status:
- Publisher copy:
- Copyright date:
Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party.
If you are the owner of this record, you can report an update to it here: Report update to this record